DEA Guidance on Medication Assisted Treatment (MAT) Evaluations by Telephone
Employment Law Report

April 3, 2020

Normally, an Opioid Treatment Program (OTP) must conduct an in-person medical evaluation of a patient before prescribing or directly dispensing controlled substances, including buprenorphine; but the COVID-19 health emergency has caused regulating bodies to modify this requirement. Click here to read the full article.

Search this Blog

Media Contact

Recent Posts

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.